📊 TOXR Key Takeaways
Is 21Shares XRP ETF (TOXR) a Good Investment?
This ETF structure exhibits severe financial deterioration with $36M net losses on $247.7M assets (14.5% loss), indicating poor 2025 performance or significant fee drag relative to underlying XRP exposure. Critical data gaps prevent comprehensive analysis, with missing revenue, cash flow, and operational metrics typical of exchange-listed funds. While the fund maintains adequate solvency with minimal debt and substantial equity cushion, the absence of profitability and limited publicly available fundamentals create elevated uncertainty around fund viability and performance quality.
Why Buy 21Shares XRP ETF Stock? TOXR Key Strengths
- Zero leverage with negligible liabilities ($35.3K) reduces default risk
- Substantial equity base ($247.7M) provides buffer against further asset deterioration
- Conservative balance sheet structure with no debt burden
TOXR Stock Risks: 21Shares XRP ETF Investment Risks
- Significant net loss of $36M (14.5% of assets) signals poor fund performance or excessive fee structure
- Severe data insufficiency with only 10 of ~30+ metrics available; missing revenue, cash flow, and profitability analysis
- ETF structure with incomplete disclosures prevents assessment of expense ratios, AUM composition, and benchmark tracking efficiency
- Negative ROE/ROA (-14.5%) indicates value destruction relative to shareholder equity
Key Metrics to Watch
- Fund net losses trend and year-over-year improvement
- Total assets under management and shareholder redemption flows
- Expense ratio and total cost of ownership vs. passive benchmark
21Shares XRP ETF (TOXR) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
TOXR Profit Margin, ROE & Profitability Analysis
TOXR vs Market Sector: How 21Shares XRP ETF Compares
How 21Shares XRP ETF compares to Market sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is 21Shares XRP ETF Stock Overvalued? TOXR Valuation Analysis 2026
Based on fundamental analysis, 21Shares XRP ETF has mixed fundamental signals relative to the Market sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
21Shares XRP ETF Balance Sheet: TOXR Debt, Cash & Liquidity
TOXR Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: 21Shares XRP ETF's revenue has remained relatively flat over the 5-year period, with a 0% decline.
TOXR Revenue Growth, EPS Growth & YoY Performance
TOXR SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for 21Shares XRP ETF (CIK: 0002028835)
📋 Recent SEC Filings
❓ Frequently Asked Questions about TOXR
What is the AI rating for TOXR?
21Shares XRP ETF (TOXR) has an AI rating of SELL with 45% confidence, based on fundamental analysis of SEC EDGAR filings.
What are TOXR's key strengths?
Claude: Zero leverage with negligible liabilities ($35.3K) reduces default risk. Substantial equity base ($247.7M) provides buffer against further asset deterioration.
What are the risks of investing in TOXR?
Claude: Significant net loss of $36M (14.5% of assets) signals poor fund performance or excessive fee structure. Severe data insufficiency with only 10 of ~30+ metrics available; missing revenue, cash flow, and profitability analysis.
What is TOXR's revenue and growth?
21Shares XRP ETF reported revenue of N/A.
Does TOXR pay dividends?
21Shares XRP ETF does not currently pay dividends.
Where can I find TOXR SEC filings?
Official SEC filings for 21Shares XRP ETF (CIK: 0002028835) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is TOXR's EPS?
21Shares XRP ETF has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is TOXR a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, 21Shares XRP ETF has a SELL rating with 45% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is TOXR stock overvalued or undervalued?
Valuation metrics for TOXR: ROE of -14.5% (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy TOXR stock in 2026?
Our dual AI analysis gives 21Shares XRP ETF a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is TOXR's free cash flow?
21Shares XRP ETF's operating cash flow is N/A, with capital expenditures of N/A.
How does TOXR compare to other Market stocks?
Vs Default sector averages: Net margin N/A (avg: 12%), ROE -14.5% (avg: 15%), current ratio N/A (avg: 1.8).